KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Acquisitions & Divestments (2016 - 2026)

Supernus Pharmaceuticals has reported Change in Acquisitions & Divestments over the past 15 years, most recently at $39.3 million for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 70.43% to $39.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $774.5 million through Dec 2025, up 55.25% year-over-year, with the annual reading at $774.5 million for FY2025, 55.25% up from the prior year.
  • Change in Acquisitions & Divestments was $39.3 million for Q4 2025 at Supernus Pharmaceuticals, down from $468.6 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $468.6 million in Q3 2025 and troughed at $17.6 million in Q4 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $72.1 million (2021), against an average of $118.3 million.
  • Year-over-year, Change in Acquisitions & Divestments plummeted 95.36% in 2022 and then soared 729.88% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $378.0 million in 2021, then plummeted by 95.36% to $17.6 million in 2022, then soared by 102.87% to $35.6 million in 2023, then skyrocketed by 273.5% to $133.0 million in 2024, then tumbled by 70.43% to $39.3 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Change in Acquisitions & Divestments are $39.3 million (Q4 2025), $468.6 million (Q3 2025), and $110.4 million (Q2 2025).